ArticleOncology reports2014

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.

Huaqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.